Team:SZU-China/HP overview




Inflammatory bowel disease (IBD) is a chronic, non-specific inflammatory reaction mainly manifested in the intestinal mucosa. This disease has a long period of onset, is difficult to cure, easy to recurrence and potential cancer risk. It is divided into Crohn's disease (CD) and Ulcerative colitis (UC). Because of the disease, IBD patients' diets need to be severely restricted. At the same time, conventional drug treatment only brings limited efficacy to patients. However, the side effects, high cost, long period of treatment, and other physical and mental pain behind it can not be underestimated, which will cause a significant impact on patients' quality of life. Based on this, we decided to start from the needs of IBD patients and develop a product for them.

Human practice is one of the most critical works in the iGEM competition, as it will affect all other aspects of our project. In order to carry out responsible innovation and create the best product and user experience, after we determined that the program was for IBD patients, we still kept thinking about: Who are we developing products for? How will we develop the product? How do we design products that best fit their needs? How can we deliver the final product to them...

Throughout the design and implementation of the project, we have been engaged in an in-depth and comprehensive dialogue with stakeholders, including many experts, scholars, and even other teams, trying to answer these questions and integrating various important considerations into our final design, product, and entrepreneurial plan.

Our Human Practice focuses on two points:
  • Identifies the most authentic and urgent needs of IBD patients, defends their rights and interests for a better life, and ensures that our project design and everything we do is meaningful.
  • Demonstrates the feasibility and pushes the project further and higher.
Timeline of our Human Practice